John R. Cashman

955 total citations
31 papers, 769 citations indexed

About

John R. Cashman is a scholar working on Pharmacology, Biochemistry and Molecular Biology. According to data from OpenAlex, John R. Cashman has authored 31 papers receiving a total of 769 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 9 papers in Biochemistry and 5 papers in Molecular Biology. Recurrent topics in John R. Cashman's work include Pharmacogenetics and Drug Metabolism (9 papers), Metabolism and Genetic Disorders (5 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). John R. Cashman is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Metabolism and Genetic Disorders (5 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). John R. Cashman collaborates with scholars based in United States and Czechia. John R. Cashman's co-authors include Noureddine Lomri, Daniel M. Ziegler, Jun Zhang, Clifford E. Berkman, Annika Braun, Elliott Sigal, Lifen Xu, Arnold M. Falick, Aaron Janowsky and Shenheng Guan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Analytical Biochemistry.

In The Last Decade

John R. Cashman

31 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John R. Cashman United States 18 282 258 150 138 104 31 769
Adelbert E. Wade United States 17 314 1.1× 246 1.0× 132 0.9× 72 0.5× 100 1.0× 53 866
Azara Janmohamed United Kingdom 10 293 1.0× 337 1.3× 94 0.6× 154 1.1× 138 1.3× 15 853
H Staudinger Germany 18 320 1.1× 416 1.6× 170 1.1× 99 0.7× 101 1.0× 65 995
J. Van Cantfort Belgium 15 352 1.2× 270 1.0× 127 0.8× 204 1.5× 40 0.4× 33 864
Charlotte Witmer United States 19 402 1.4× 515 2.0× 157 1.0× 145 1.1× 43 0.4× 41 1.5k
Sybil P. James United Kingdom 17 195 0.7× 360 1.4× 308 2.1× 85 0.6× 85 0.8× 48 1000
J. A. Miller United States 8 379 1.3× 352 1.4× 142 0.9× 126 0.9× 73 0.7× 11 929
Heinz Frank Germany 18 193 0.7× 440 1.7× 89 0.6× 93 0.7× 46 0.4× 47 1.1k
Patricia E. Levi United States 21 474 1.7× 365 1.4× 82 0.5× 211 1.5× 48 0.5× 51 1.4k
W. Koransky Germany 19 319 1.1× 368 1.4× 132 0.9× 132 1.0× 75 0.7× 65 1.1k

Countries citing papers authored by John R. Cashman

Since Specialization
Citations

This map shows the geographic impact of John R. Cashman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John R. Cashman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John R. Cashman more than expected).

Fields of papers citing papers by John R. Cashman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John R. Cashman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John R. Cashman. The network helps show where John R. Cashman may publish in the future.

Co-authorship network of co-authors of John R. Cashman

This figure shows the co-authorship network connecting the top 25 collaborators of John R. Cashman. A scholar is included among the top collaborators of John R. Cashman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John R. Cashman. John R. Cashman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Sigeng, Jun Zhang, Lucille A. Lumley, & John R. Cashman. (2012). Immunodetection of Serum Albumin Adducts as Biomarkers for Organophosphorus Exposure. Journal of Pharmacology and Experimental Therapeutics. 344(2). 531–541. 23 indexed citations
2.
Zhang, Jun, et al.. (2007). Functional activity of the mouse flavin‐containing monooxygenase forms 1, 3, and 5. Journal of Biochemical and Molecular Toxicology. 21(4). 206–215. 28 indexed citations
3.
Zhang, Jun, Quyen Tran, Virginie Lattard, & John R. Cashman. (2003). Deleterious mutations in the flavin-containing monooxygenase 3 (FMO3) gene causing trimethylaminuria. Pharmacogenetics. 13(8). 495–500. 35 indexed citations
4.
Cashman, John R., et al.. (1995). Role of hepatic flavin-containing monooxygenase 3 in drug and chemical metabolism in adult humans. Chemico-Biological Interactions. 96(1). 33–46. 58 indexed citations
5.
6.
Lomri, Noureddine, et al.. (1993). Regio- and stereoselective oxygenations by adult human liver flavin-containing monooxygenase 3. Comparison with forms 1 and 2. Chemical Research in Toxicology. 6(6). 800–807. 28 indexed citations
7.
Vamvakas, Spyridon, et al.. (1992). Flavin-containing monooxygenase-dependent stereoselective S-oxygenation and cytotoxicity of cysteine S-conjugates and mercapturates. Chemical Research in Toxicology. 5(2). 193–201. 29 indexed citations
8.
Cashman, John R., et al.. (1992). Structure-retention index relationships for derivatized monosaccharides on non-polar gas chromatography columns. Journal of Chromatography A. 596(1). 79–84. 2 indexed citations
9.
Decker, Caroline J., John R. Cashman, Katsumi Sugiyama, David Maltby, & Maria Almira Correia. (1991). Formation of glutathionyl-spironolactone disulfide by rat liver cytochromes P450 or hog liver flavin-containing monooxygenases: a functional probe of two-electron oxidations of the thiosteroid?. Chemical Research in Toxicology. 4(6). 669–677. 12 indexed citations
10.
Guan, Shenheng, Arnold M. Falick, D E Williams, & John R. Cashman. (1991). Evidence for complex formation between rabbit lung flavin-containing monooxygenase and calreticulin. Biochemistry. 30(41). 9892–9900. 38 indexed citations
11.
Cashman, John R., et al.. (1990). Oxidation of N-hydroxynorzimeldine to a stable nitrone by hepatic monooxygenases. Chemical Research in Toxicology. 3(5). 428–432. 11 indexed citations
12.
Cashman, John R., et al.. (1989). Canrenone formation via general-base-catalyzed elimination of 7.alpha.-(methylthio)spironolactone S-oxide. Chemical Research in Toxicology. 2(2). 109–113. 7 indexed citations
13.
Cashman, John R., et al.. (1989). S-Oxygenation of eptam in hepatic microsomes from fresh- and salt water striped bass (Morone saxatilis). Chemical Research in Toxicology. 2(6). 392–399. 23 indexed citations
14.
15.
Cashman, John R., Charles C. Lambert, & Elliott Sigal. (1988). Inhibition of human leukocyte 5-lipoxygenase by 15-HPETE and related eicosanoids. Biochemical and Biophysical Research Communications. 155(1). 38–44. 17 indexed citations
16.
Cashman, John R. & John Proudfoot. (1988). A reverse-phase liquid chromatographic assay for flavin-containing monooxygenase activity. Analytical Biochemistry. 175(1). 274–280. 3 indexed citations
17.
Sigal, Elliott, et al.. (1988). Arachidonate 15-lipoxygenase from human eosinophil-enriched leukocytes: Partial purification and properties. Biochemical and Biophysical Research Communications. 150(1). 376–383. 51 indexed citations
18.
Cashman, John R.. (1987). A convenient radiometric assay for flavin-containing monooxygenase activity. Analytical Biochemistry. 160(2). 294–300. 12 indexed citations
19.
Cashman, John R., et al.. (1987). Epoxy Derivatives of Arachidonic Acid Are Potent Stimulators of Prolactin Secretion. Neuroendocrinology. 46(3). 246–251. 46 indexed citations
20.
Cashman, John R.. (1983). Hazardous materials emergencies: Response and control. Medical Entomology and Zoology. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Adelbert E. Wade Breakdown of academic impact, for papers by Azara Janmohamed Breakdown of academic impact, for papers by H Staudinger Breakdown of academic impact, for papers by J. Van Cantfort Breakdown of academic impact, for papers by Charlotte Witmer Breakdown of academic impact, for papers by Sybil P. James Breakdown of academic impact, for papers by J. A. Miller Breakdown of academic impact, for papers by Heinz Frank Breakdown of academic impact, for papers by Patricia E. Levi Breakdown of academic impact, for papers by W. Koransky
Rankless by CCL
2026